Evaluation of efficacy in improvement of cardiac function / renal function by REZALTAS COMBINATION TABLETS on hypertension patient.
Not Applicable
- Conditions
- hypertension
- Registration Number
- JPRN-UMIN000005140
- Lead Sponsor
- Kanazawa Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Secondary hypertension 2)Known history of cerebral apoplexy. 3)Hyperkalemia (K>5.0mEq/L) 4)Serum Cr>3.0mg/dl 5)Severe hepatic disease. 6)Woman who are pregnant or woman of childbearing potential. 7)Patient who has olmesartan allergy or azelnidipine allergy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method